Activated PI3K Delta Syndrome (APDS) Latest Advances
Find the Latest Research About Activated PI3K Delta Syndrome (APDS)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Leniolisib and rapamycin in Activated PI3-Kinase-δ-syndrome: a retrospective ESID registry-based analysis.
Journal: The Journal of allergy and clinical immunology
Published: August 03, 2026
Diagnosing primary immunodeficiencies using protein-based screening assays.
Journal: Clinical and experimental immunology
Published: June 18, 2026
Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue.
Journal: Frontiers in immunology
Published: May 14, 2026
APDS treatment in Germany: decision criteria, costs and contribution of leniolisib to outcomes.
Journal: Frontiers in immunology
Published: March 30, 2026
Inborn Errors of Immunity Linked to Cryptosporidiosis.
Journal: The Journal of infectious diseases
Published: March 18, 2026
Allergic airway reactions rewired by PI3Kδ mutation.
Journal: The Journal of experimental medicine
Published: February 20, 2026
Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).
Journal: The Journal of infectious diseases
Published: January 21, 2026
Shrinking Spleens and Nodes, Expanding Horizons: Leniolisib and the Future of Activated Phosphoinositide 3-Kinase Delta Syndrome.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 19, 2025
Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.
Journal: Frontiers in immunology
Published: December 08, 2025
Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus.
Journal: Frontiers in immunology
Published: November 13, 2025
Evaluating the impact of leniolisib treatment on symptoms and health-related quality of life in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.
Journal: Frontiers in immunology
Published: November 04, 2025
Activated PI3Kδ syndrome in inborn errors of immunity: diagnostic strategies and clinical challenges.
Journal: Frontiers in immunology
Published: October 29, 2025
Last Updated: 11/08/2026